It is commonly discussed in wellness and recovery protocols because of its association with cellular migration, tissue repair processes, mobility support, and systemic recovery support
However, it distinguishes itself by acting on two additional hormones: glucose-dependent insulinotropic polypeptide (GIP), which aids in blood sugar management, and glucagon, which can help suppress appetite and increase energy expenditure
Semaglutide reduced systolic blood pressure by 3.3 mm Hg, high-sensitivity C-reactive protein by 37.8%, and improved lipid profilesall achieved on top of high baseline rates of evidence-based cardiovascular therapies (90% on statins, 86% on antiplatelet agents).[1] These pleiotropic effects likely contribute to cardiovascular risk reduction through mechanisms distinct from adiposity changes, supporting the reconceptualization of GLP-1 receptor agonists as cardiovascular disease-modifying agents rather than simply weight-loss medications
ThriveMD can make sure your body maintains its best chance to restore functionality and avoid injury